FIRST TRACKS BIOTHERAPEUTICS, INC. Capital Expenditures Incurred but Not yet Paid
FIRST TRACKS BIOTHERAPEUTICS, INC. (TRAX) reported Capital Expenditures Incurred but Not yet Paid of $23.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-14
- FIRST TRACKS BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $23.00K, a 109.09% increase year-over-year.
- FIRST TRACKS BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $11.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month |
|---|---|
| 2026-03-31 | $23.00K 10-Q · filed 2026-05-14 |
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |